Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Borner

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Onkologie|October 6, 2005
[Clinical development of targeted moledular cancer drugs]Heinz Zwierzina, Markus Borner
Oecologia|March 18, 2017
Population regulation of Serengeti Wildebeeest: a test of the food hypothesisA R E Sinclair, H Dublin, Markus Borner
International Journal of Surgical Oncology|August 18, 2012
Role of intra- and peritumoral budding in the interdisciplinary management of rectal cancer patientsInti Zlobec, Markus Borner, Alessandro Lugli, et al.
Nature|February 1, 2013
Revived species: where will they live?J Grant C Hopcraft, Markus Borner, Daniel T Haydon
Plos One|July 23, 2015
Balancing Conservation with National Development: A Socio-Economic Case Study of the Alternatives to the Serengeti RoadJ Grant C Hopcraft, Gerald Bigurube, James Daudi Lembeli, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|May 29, 2007
Assessment of effectiveness of protection strategies in Tanzania based on a decade of survey data for large herbivoresChantal Stoner, Tim Caro, Simon Mduma, et al.
Oncology Research and Treatment|March 9, 2020
Metastatic Colorectal Carcinoma after Second Progression and the Role of Trifluridine-Tipiracil (TAS-102) in SwitzerlandAlexander Siebenhüner, Sara De Dosso, Alexander Meisel, et al.
Oncology (Williston Park, N.Y.)|April 24, 2009
Management of infusion reactions in clinical trials and beyond: the US and EU perspectivesAnthony J Cmelak, Florian Lordick, Markus Borner, et al.
European Journal of Cancer (Oxford, England : 1990)|August 29, 2006
Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patientsMarc Salzberg, Markus Borner, Jean-Alexandre Bauer, et al.
Digestive Diseases and Sciences|February 22, 2002
Bile duct infarction following intraarterial hepatic chemotherapy mimicking multiple liver metastasis: report of a case and review of the literatureShailesh Shrikhande, Helmut Friess, Jörg Kleeff, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Onkologie|October 6, 2005
[Clinical development of targeted moledular cancer drugs]Heinz Zwierzina, Markus Borner
Oecologia|March 18, 2017
Population regulation of Serengeti Wildebeeest: a test of the food hypothesisA R E Sinclair, H Dublin, Markus Borner
International Journal of Surgical Oncology|August 18, 2012
Role of intra- and peritumoral budding in the interdisciplinary management of rectal cancer patientsInti Zlobec, Markus Borner, Alessandro Lugli, et al.
Nature|February 1, 2013
Revived species: where will they live?J Grant C Hopcraft, Markus Borner, Daniel T Haydon
Plos One|July 23, 2015
Balancing Conservation with National Development: A Socio-Economic Case Study of the Alternatives to the Serengeti RoadJ Grant C Hopcraft, Gerald Bigurube, James Daudi Lembeli, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|May 29, 2007
Assessment of effectiveness of protection strategies in Tanzania based on a decade of survey data for large herbivoresChantal Stoner, Tim Caro, Simon Mduma, et al.
Oncology Research and Treatment|March 9, 2020
Metastatic Colorectal Carcinoma after Second Progression and the Role of Trifluridine-Tipiracil (TAS-102) in SwitzerlandAlexander Siebenhüner, Sara De Dosso, Alexander Meisel, et al.
Oncology (Williston Park, N.Y.)|April 24, 2009
Management of infusion reactions in clinical trials and beyond: the US and EU perspectivesAnthony J Cmelak, Florian Lordick, Markus Borner, et al.
European Journal of Cancer (Oxford, England : 1990)|August 29, 2006
Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patientsMarc Salzberg, Markus Borner, Jean-Alexandre Bauer, et al.
Digestive Diseases and Sciences|February 22, 2002
Bile duct infarction following intraarterial hepatic chemotherapy mimicking multiple liver metastasis: report of a case and review of the literatureShailesh Shrikhande, Helmut Friess, Jörg Kleeff, et al.
Pageof 5